GUTS vs VTRS · $74.9M cap vs rev $7.27B
Fractyl Health, Inc. Common Stock (GUTS) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Fractyl Health, Inc. Common Stock (GUTS) is a biotechnology company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported GUTS revenue for 2025-12-31 was $0. Net income was -$141.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. GUTS currently screens at market cap $74.9M.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
GUTS currently screens at market cap $74.9M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the GUTS and VTRS stock pages for the full models.
Not investment advice.